Alpha 2.0
Login Register
» Articles » PMID: 99234

Chemotherapeutic Management of Carcinoma of the Bilharzial Bladder: a Phase II Trial with Hexamethylmelamine and VM-26

Overview
Journal Cancer Treat Rep
Specialty Oncology
Date 1978 Jul 1
PMID 99234
Citations 4
Authors
F M Muggia
M R Hamza
M Sherif
M A Mansour
M Khafagy
Affiliations
Soon will be listed here.
Citing Articles

Altretamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cancer chemotherapy.

Lee C, Faulds D Drugs. 1995; 49(6):932-53.

PMID: 7641606 DOI: 10.2165/00003495-199549060-00007.

VM26: phase I and II studies.

Macbeth F Cancer Chemother Pharmacol. 1982; 7(2-3):87-91.

PMID: 7044595 DOI: 10.1007/BF00254527.

Pentamethylmelamine (PMM): Phase I clinical and pharmacokinetic studies.

Muindi J, Newell D, Smith I, HARRAP K Br J Cancer. 1983; 47(1):27-33.

PMID: 6401427 PMC: 2011259. DOI: 10.1038/bjc.1983.3.

Update in cancer chemotherapy: genitourinary tract cancer, Part 2: Wilms' tumor and bladder cancer.

Wright J J Natl Med Assoc. 1988; 80(2):169-81.

PMID: 2853770 PMC: 2625724.